Devascularization for Portal Hypertension not Obsolete: Technical Details and Experience of 104 Cases

Title: Devascularization for Portal Hypertension not Obsolete: Technical Details and Experience of 104 Cases

Authors: Sadaf Ali, Omar J Shah, K Sudarshan Reddy, Faroze Khan, Ajaz A Wani

DOI: https://dx.doi.org/10.18535/jmscr/v5i5.101

Abstract

Background- Portal hypertension of various etiologies results in various complications, of which most common and dreaded complication is esophago-gastric varices and its bleed. Devascuarisation with our modified technique has a vital role in the management of esophago-gastric vertices, it’s not obsolete procedure.

Methods- A Prospective study of 104 patients underwent our modified Devascularization procedure over a period of 8 years from January 2006 to December 2014 in surgical gastroenterology department, SKIMS, INDIA. These patients had a follow up of 8 years to minimum of 1 year. The study patients were compiled in 2015.

Results- In our study with our Devascularisation technique, the operative time was 150 mins+/- 30 min, operative blood loss was300 ml +/- 50 ml, during post operative follow up there was no esophageal leak or stenosis, noresidualvarices (0%) and noencephalopathy observed. In12 patients developed recurrentvarices (12.53%), rebleeding occurred in 8(7.69%) patients and 9 patients were died (8.65%), all of them were Child C.

Conclusion- In failed medical and endoscopic management of esophagogastric varicesour devascularisation technique has an important role, with less post operative morbidity and mortality and its role will only continue to evolve .

Keywords- Esophago-gasricvarices, our devascularistion technique, portosystemic shunts, recurrent varices, rebleed, encephalopathy, mortality.

References

1. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M.Portal pressure, presence of gastroesophagealvarices and variceal bleeding. Hepatology 1985; 5: 419–424.

2. Schlichting P, Christensen E, Fauerholdt L, Poulsen H, Juhl E, Tygstrup N. Main causes of death in cirrhosis. Scand J Gastroenterol.1982; 18: 881–888.

3. Benhamou JP, Valla D. Intrahepatic portal hypertension. In: Bircher J,Benhamou JP, McIntyre N, Rizzatto M, Rodes J, eds. Clinical Hepatology.Oxford, UK: Oxford Univ Press; 1999:661–669.

4. Sugiura M, Futagawa S. Results of six hundred thirty-six esophageal transections with paraesophagogastricdevascularization in the treatment of esophageal varices. J VascSurg.1984;1:254.

5. Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol. 2008; 48 (Suppl1):S68.

6. Iwarsuki S, Starzl T E, Todo S, , Gordon RD, Tzakis AG, Marsh JW, et al. Liver transplantation in the treatment of bleeding esophageal varices. Surgery. 1988 Oct;104(4):697-705.

7. Henderson JM. Liver transplantation for portal hypertension.GastroenterolClin North Am. 1992;21:197.

8. Ringe B, Lang H, Tusch G, Pichlmayr R. role of liver transplantation in management of esophageal variceal hemorrhage. World J Surg. 1994;18:233.

9. Abu-Elmagd K, Iwatsuki S. Portal hypertension: role of livertransplantation. In: Cameron J, ed. Current Surgical Therapy, 7th ed. St. Louis, MO:Mosby; 2001:406–413.

10. Dagenasi M, Langer B, Taylor B R, Grieg P D. Experience with radical esophagogastric devascularization procedures (Sugiura) for variceal bleeding outside Japan. World J Surg. 1994;18:222–228.

11. Inokuchi, K.: Present status of surgical treatment of esophageal varicesin Japan: a nationwide survey of 3,588 patients. World J. Surg.9:171, 1985.

12. Idezuki, Y., Kokudo, N., Sanjo, K., Bandai, Y.: Sugiura procedure forthe management of variceal bleeding in Japan. World J. Surg.1994;18:216.

13. Viallet A, Marleau D, Huet M, Martin F, Farley A, Villeneuve JP, et al. Hemodynamic evaluation of patients with intrahepatic portal hypertension. Gastroenterology 1975; 69: 1297–1300.

14. Bosch J, Abraldes JG, Berzigotti A, Garcia-Pagan JC. Portal hypertension and gastrointestinal bleeding.Semin Liver Dis. 2008 Feb;28(1):3-25.

15. Bellot P, García-Pagán JC, Abraldes JG, Bosch J. Primary prophylaxis of esophageal variceal bleeding in cirrhosis. GastroenterolClin Biol. 2008 May;32(5 Pt 1):532-40.

16. Child CG. The liver and portal hypertension. Philadelphia, W.B. Saunders; 1964.pp.50.

17. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC and Williams R. Transection of the oesophagus for bleeding oesophagealvarices.Br J Surg 1973; 60: 646–649.

18. Schalm SW, van Buuren HR. Prevention of recurrent variceal bleeding: Nonsurgical procedures. ClinGastroenterol 1985; 14: 209–232.

19. Pinto HC, Abrantes A, Esteves AV, Almeida H, Correia JP. Long-term prognosis of patients with cirrhosis of the liver and upper gastrointestinal bleeding.Am J Gastroenterol.1989; 84: 1239–1243.

20. Pagliaro L, D’Amico G, Sorensen TIA, Lebrec D, Burroughs AK, MorabitoA,et al. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment.Ann Intern Med. 1992; 117: 59–70.

21. Wang Y. Surgical treatment of portal hypertension. HPD Int.2002;1:211-214.

22. Garcia-Tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding.Unresolved issues.Hepatology. 2008;47:1764–1772.

23. de Franchis R, Dell’Era A, Iannuzzi F. Diagnosis and treatment of portal hypertension. Digest Liver Dis. 2004;36:787–798.

24. Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: Rational basis, available treatments and future options. J Hepatol. 2008;48: 68–92.

25. Orozco H, Mercado MA, Takahashi T. Survival and quality of life after portal blood flow preserving procedures in patients with portal hypertension and liver cirrhosis. Am J Surg. 1994;168:10–14.

26. Borgonovo G, Costantini M, Grange D, Vons C, Smadja C ,Franco D. Comparison of a modified Sugiura procedure with portal systemic shunt for prevention of recurrent bleeding in cirrhosis. Surgery. 1996;119:214–221.

27. Wang ZH, Cai HZ, Zhao AX, Qiu YD, Li LP. The effects of disconnection and shunt procedure on hepatic hemodynamics and function of active cirrhotic patients with portal hypertension.Chinese J of ClinHepatol. 2002;118:309–310.

28. Da Silva LC, Strauss E, Gayotto LCC. A randomized trial for the study of the elective surgical treatment of portal hypertension in mansonicschistosomiasis,” Ann Surg. 1986;204:148–153.

29. DeCleva R, Herman P, D'albuquerque LA. Pre- and postoperative systemic hemody-namic evaluation in patients subjected to esophagogastric devascularization plus splenectomy and distal splenorenal shunt: a comparative study in schistomomal portal hypertension. World J Gastroenterol. 2007;13:5471-5475.

30. Rekkers LF, Jin G. Surgical management of acute variceal heamorrhage.World J.Surg.1994;18:193-9.

31. Bhalerao RA, Pinto AC, Bapat RD, Shetty SV, Bhide PD, Waingankar VS, et al. Selective trans-splenic decompression of oesophagealvarices by distal spenorenal and splenocaval shunt. Gut.1978;19:831-7.

32. Orozco H, Takahashi T, Mercado MA, Garica-Tsao G,Hernandez-Ortiz J. The sugiura procedure for patients with hemorrhagic portal hypertension secon-dary to extra hepatic portal vein thrombosis. Surg Gynaeco Obstet. 1991;173:45-8.

33. Potts JR III, Henderson JM, Millikan WJ Jr, Warren WD. Emergency distal spenorenal shunts for variceal hemorrhage refractory to non operative control. Am J Surg.1984;148:813-6.

34. LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan RK Jr, Ascher NL, et al. Two-year outcome following transju-gular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology. 1995 Apr;108(4):1143-51.

35. Kerlan RK Jr, LaBerge JM, Gordon RL, Ring EJ. Transjugular intrahepatic portos-ystemic shunts: current status.AJR Am J Roentgenol. 1995 May;164(5):1059-66.

36. Langer BF,Greg PD, Taylor BR. Emergency surgical treatment of variceal hemorrhage. Surgclin north Am. 1990; 70:307-11.

37. Sugiura, M., Futagawa, S.: Esophageal transection with paraesophagogastric devascularisation (the Sugiura procedure) in the treatmentof esophageal varices. World J. Surg.19848:673.

38. Idezuki, Y., Sanjyo, K.: Twenty-five-year experiences with esophagealtransection for esophageal varices. J. Thorac. Cardiovasc. Surg.1989;98:876.

39. Johnson M, Rajendran S, Balachandar TG, Kannan D, Jeswanth S, Ravichandran P, et al. Transabdominal modified devasculari-zation procedure with or without esopha-geal staplertransection--an operation adequate for effective control of a varicealbleed. Is esophageal stapler transection necessary? World JSurg.2006; 30: 1507-1518.

40. Mathur SK, Shah SR, Soonawala ZF, Karandikar SS, Nagral SS, Dalvi AN, et al. Transabdominal extensive oesophago-gastric devascuarisation with gastro-oesophageal stapling in the management of acute variceabeeding. Br J Surg. 1997;84:413-7.

41. Xie SM, Yang YJ, Han ZY, Lv FP. Different surgical procedures for potal hypertension. Chinese J of Modern Med. 2002;6:116- 118.

42. Zong GQ, Fei Y, Liu RM.Comparison of Effects of Devascularization Versus Shunt on Patients With Portal Hypertension: A Meta-Analysis. Hepatogastroenterology. 2015 Jan-Feb;62(137):144-50.

43. Mathur, S.K., Dalvi, A.N., Someshwar, V., Supe, A.N., Ramakantan R. Endoscopic and radiological appraisal of gastric varices. Br. J.Surg.1990;77:432.

44. Koyanagi, N., Iso, Y., Higashi, H., Kitano, S., Sugimachi, K. Recurrenceof varices after esophageal transection: intraoperative and postoperative assessment by endoscopy. Br. J. Surg.1988;75:9.

45. Umeyama, K., Yoshikawa, K., Yamashita, T., Todo, T., Satake, K. Trans abdominals-ophageal transection for esophageal varices: experiencein 101 patients. Br. J Surg.1983; 70:419.

46. Hoskings, S.W., Johnson, A.G.What hap-pens to esophageal varicesafter transection and devascularisation? Surgery.1987; 101:531.

47. Cao H, Hua R, Wu ZY. Effects of combined splenorenal shunt devascularization and devascularization only on hemo-dynamics of the portal venous system in -patients with portal hypertension. Hepatobiliary Pancreat Dis Int. 2005 Aug;4(3):385-8.

48. Bosoi CR, Rose CF. Oxidative stress: a systemic factor implicatedin the pathogenesis of hepatic encephalopathy. Metab Brain Dis. 2013;28:175-178.

49. Ohta M, Shimada T, Matsufuji H, Yukizane T, Yamada H. Surgical treatment of a patient with idiopathic portal hypertension and hepatic encephalopathy. Hepatogastroenterology. 2001;48:1461-1463.

50. Rikkers LF, Rudman D, Galambos JT, Fulenwider JT, Millikan WJ, KutnerM,et al. A randomized, controlled trial of the distal splenorenalshunt.Ann Surg. 1978 Sep;188(3):271-82.

51. Bernard B, Cadranel JF, Valla D, Escolano S, Jarlier V, Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology. 1995;108:1828–1834.

52. Gu DY, Xu WG, Lin ZP. Liver function reserve in surgical treatment of patients with portal hypertension: report of 146 cases. Hepatobiliary Pancreat Dis Int. 2002;1:515-518.

53. Orloff MJ, Orloff MS, Orloff SL, Rambotti M, Girdad B. Three decades of experience with emergency portocava shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver, J Am Coll Surg. 1995;180:257-72.

54. Hassab MA. Gastro-esophageal decongestion and splenectomy GEDS (Hassab), in the management of bleeding varices. Review of literature. Int Surg.1998 Jan- Mar; 83(1):38-41.

55. Inokuchi K. Present status of surgical treatment of esophageal varices in Japan: a nationwide survey of 3,588 patients. World J Surg. 1985 Feb;9(1):171-80.

Abstract

References

Corresponding Author

Call For Paper Volume 12 Issue 12 December 2024

JMSCR Menu

Impact Factor SJIF 2024: 7.892

Crossref - DOI

Editorial Policy

Frequency of Publication

Submission of Articles

Search

Abstract

Call For Paper Volume 12 Issue 12 December 2024

JMSCR Menu

Impact Factor SJIF 2024: 7.892

Crossref - DOI

Editorial Policy

Frequency of Publication

Submission of Articles